Baidu’s Dual AI Strategy Gains Momentum with Key Breakthroughs

Baidu is making strategic moves on multiple fronts that could significantly enhance its standing in the global artificial intelligence competition. The Chinese technology conglomerate is seeing promising developments through its affiliated biotechnology firm BioMap and aggressive international expansion of its autonomous vehicle division Apollo Go.

Autonomous Driving Unit Accelerates Global Presence

Baidu’s self-driving vehicle subsidiary Apollo Go is rapidly extending its international footprint following a successful Dubai launch. In September 2025, the company secured the first autonomous driving test approval in Dubai along with 50 testing licenses. The operation now has ambitious plans to scale its Dubai fleet to 100 vehicles, with a target of deploying more than 1,000 fully driverless vehicles by 2028.

According to Halton Niu, General Manager of Overseas Business at Baidu’s Intelligent Driving Group, the company is currently engaged in discussions with government authorities across Southeast Asia and Australia regarding pilot programs and service launches. This international push represents a significant step in Baidu’s strategy to commercialize its autonomous driving technology beyond domestic markets.

BioMap Challenges AlphaFold in Drug Discovery

In a separate development with potential long-term implications, Baidu-backed BioMap claims to have surpassed Google’s AlphaFold in commercially viable AI-driven drug development. The biotechnology company, founded by Baidu co-founder Robin Li Yanhong and former Baidu Ventures chief Wei Liu, has announced the establishment of a new Hong Kong-based entity focused on bringing novel pharmaceuticals to market.

Should investors sell immediately? Or is it worth buying Baidu?

If BioMap’s technological assertions prove accurate, this Baidu-associated enterprise could position itself at the forefront of a highly profitable key industry, creating substantial long-term revenue potential beyond Baidu’s core business operations.

Investor Confidence Strengthens

These strategic advancements appear to be resonating with institutional investors. ARK Investment Management, led by Cathie Wood, significantly increased its Baidu holdings on October 1, 2025, purchasing an additional 21,600 shares. This move signals growing confidence in Baidu’s technology-driven growth strategy among prominent investment firms.

The upcoming quarterly results, expected in November, may provide initial indications of whether Baidu’s dual offensive in artificial intelligence and autonomous driving is translating into competitive advantages and financial performance.